Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Randomized Control Trial of Conventional Hemodialysis Versus Post-Dilution Hemofiltration as First Treatment of Renal Replacement Therapy in Chronic Kidney Disease: The DA-VINCI Study

NCT05060159 is registered in ClinicalTrials.gov with Instituto Nacional de Cardiologia Ignacio Chavez as lead sponsor.

NCT NCT05060159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Randomized Control Trial of Conventional Hemodialysis Versus Post-Dilution Hemofiltration as First Treatment of Renal Replacement Therapy in Chronic Kidney Disease: The DA-VINCI Study
Lead sponsor
Instituto Nacional de Cardiologia Ignacio Chavez
Phase
Not applicable
Overall status
Completed
Start date
January 6, 2020
Completion date
July 1, 2021
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral edema, cognitive impairment, dialysis; complications, hemodialysis complication